|
 |
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 4:377-383, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Antibody Arrays in Cancer Research
From the Van Andel Research Institute, Grand Rapids, Michigan 49503
Antibody arrays have valuable applications in cancer research. Many different antibody array technologies have been developed, each with particular advantages, disadvantages, and optimal applications. The methods have been demonstrated on various sample types, such as serum, plasma, and other bodily fluids; cell culture supernatants; tissue culture lysates; and resected tumor specimens. The applications to cancer research have included profiling proteins to identify candidate biomarkers, characterizing signaling pathways, and the measurement of changes in modification or expression level of cancer-related proteins. Further innovations in the methods and experimental strategies are broadening the scope of the applications and the type of information that can be gathered. These alternate formats and uses of antibody arrays include arrays to measure whole cells, arrays to measure enzyme activities, reverse phase arrays, and bead-based arrays. This article reviews the various types of antibody array methods and their applications to cancer research.
To whom correspondence should be addressed: Van Andel Research Inst., 333 Bostwick, N. E., Grand Rapids, MI 49503. Tel.: 616-234-5268; Fax: 616-234-5269; E-mail: brian.haab{at}vai.org
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. P. Bearinger, G. Stone, L. C. Dugan, B. El Dasher, C. Stockton, J. W. Conway, T. Kuenzler, and J. A. Hubbell Porphyrin-based Photocatalytic Nanolithography: A NEW FABRICATION TOOL FOR PROTEIN ARRAYS Mol. Cell. Proteomics, August 1, 2009; 8(8): 1823 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kuno, Y. Kato, A. Matsuda, M. K. Kaneko, H. Ito, K. Amano, Y. Chiba, H. Narimatsu, and J. Hirabayashi Focused Differential Glycan Analysis with the Platform Antibody-assisted Lectin Profiling for Glycan-related Biomarker Verification Mol. Cell. Proteomics, January 1, 2009; 8(1): 99 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lausted, Z. Hu, and L. Hood Quantitative Serum Proteomics from Surface Plasmon Resonance Imaging Mol. Cell. Proteomics, December 1, 2008; 7(12): 2464 - 2474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Espina, K. H. Edmiston, M. Heiby, M. Pierobon, M. Sciro, B. Merritt, S. Banks, J. Deng, A. J. VanMeter, D. H. Geho, et al. A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process Mol. Cell. Proteomics, October 1, 2008; 7(10): 1998 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wu, F. Yan, X. Zhang, Y. Yan, J. Tang, and H. Ju Disposable Reagentless Electrochemical Immunosensor Array Based on a Biopolymer/Sol-Gel Membrane for Simultaneous Measurement of Several Tumor Markers Clin. Chem., September 1, 2008; 54(9): 1481 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Gul, H. Basaga, and O. Kutuk Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures Briefings in Functional Genomics, February 18, 2008; (2008) eln002v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Madoz-Gurpide, M. Canamero, L. Sanchez, J. Solano, P. Alfonso, and J. I. Casal A Proteomics Analysis of Cell Signaling Alterations in Colorectal Cancer Mol. Cell. Proteomics, December 1, 2007; 6(12): 2150 - 2164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bertucci, D. Birnbaum, and A. Goncalves Proteomics of Breast Cancer: Principles and Potential Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1772 - 1786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Kusnezow, Y. V. Syagailo, S. Ruffer, N. Baudenstiel, C. Gauer, J. D. Hoheisel, D. Wild, and I. Goychuk Optimal Design of Microarray Immunoassays to Compensate for Kinetic Limitations: Theory and Experiment Mol. Cell. Proteomics, September 1, 2006; 5(9): 1681 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ellmark, J. Ingvarsson, A. Carlsson, B. S. Lundin, C. Wingren, and C. A. K. Borrebaeck Identification of Protein Expression Signatures Associated with Helicobacter pylori Infection and Gastric Adenocarcinoma Using Recombinant Antibody Microarrays Mol. Cell. Proteomics, September 1, 2006; 5(9): 1638 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Smith, M. B. Watson, S. L. O'Kane, P. J. Drew, M. J. Lind, and L. Cawkwell The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol. Cancer Ther., August 1, 2006; 5(8): 2115 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Anderson and C. L. Hunter Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins Mol. Cell. Proteomics, April 1, 2006; 5(4): 573 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Anderson The Roles of Multiple Proteomic Platforms in a Pipeline for New Diagnostics Mol. Cell. Proteomics, October 1, 2005; 4(10): 1441 - 1444. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |